Conference Material
|
Slide Presentation
Efficacy and safety of 14-day treatment with paromomycin and miltefosine for primary visceral leishmaniasis in eastern Africa: non-inferiority trial
Solomos A,
Musa AM,
Mbui J,
Mohammed R,
Olobo J,
Ritmeijer KKD,
Alcoba G,
Muthoni Ouattara G,
Egondi T,
Nakanwagi P,
Omollo T,
Wasunna M,
Alvar J,
Alves F
View HTML
View PDF
Share
Download
Download
View PDF
Share
Similar Content
Loading...
Loading...
Loading...
Countries
Ethiopia
Kenya
Uganda
Sudan
Subject Area
pediatrics
neglected tropical diseases
kala azar
leishmaniasis
Languages
English
DOI
10.57740/81jj-tz57
Published Date
07 Jun 2023
Conference
MSF Scientific Day International 2023
Efficacy and safety of 14-day treatment with paromomycin and miltefosine for primary visceral leishmaniasis in eastern Africa: non-inferiority trial | Conference Material / Slide Presentation | MSF Science Portal
